Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: June 21, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given